ZOETIS INC's ticker is ZTS and the CUSIP is 98978V103. A total of 1,590 filers reported holding ZOETIS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polen Capital Management | 5,163,881 | $898,412,091 | 2.36% |
| Renaissance Investment Group LLC | 48,566 | $8,449,524 | 2.36% |
| Fulcrum Capital LLC | 46,043 | $8,010,619 | 2.32% |
| Douglass Winthrop Advisors, LLC | 538,613 | $93,707,890 | 2.32% |
| Security National Bank | 46,768 | $8,138,100 | 2.28% |
| BRASADA CAPITAL MANAGEMENT, LP | 54,520 | $9,516,712 | 2.22% |
| Dundas Partners LLP | 129,406 | $22,514 | 2.21% |
| New England Research & Management, Inc. | 22,228 | $3,867 | 2.20% |
| Chicago Capital, LLC | 270,136 | $46,998,221 | 2.20% |
| Seneca House Advisors | 24,126 | $4,212,407 | 2.19% |
| ALTA CAPITAL MANAGEMENT LLC/ | 174,065 | $30,283,846 | 2.18% |
| Sandhill Capital Partners LLC | 129,940 | $22,606,933 | 2.11% |
| NEVILLE RODIE & SHAW INC | 136,126 | $23,684 | 2.11% |
| 1623 Capital LLC | 28,400 | $4,941,032 | 2.11% |
| Private Wealth Partners, LLC | 126,376 | $21,986,924 | 2.10% |
| CAMDEN NATIONAL BANK | 58,727 | $10,217,323 | 2.10% |
| MARSICO CAPITAL MANAGEMENT LLC | 279,409 | $48,611,578 | 2.08% |
| Peterson Wealth Services | 15,726 | $2,735,980 | 2.05% |
| BOWEN HANES & CO INC | 346,987 | $60,368,798 | 2.03% |
| Wills Financial Group, Inc. | 21,481 | $3,737,287 | 2.02% |
About ZOETIS INC
Zoetis Inc. is a leading animal health company that specializes in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines. The company was founded in 2013 and is headquartered in Parsippany, New Jersey. Zoetis operates in more than 100 countries and has a diverse portfolio of products that cater to the needs of livestock and companion animals.
Zoetis has a strong leadership team, with Kristin Peck serving as the CEO and Juan Ramón Alaix as the Executive Chairman of the Board. The company has a robust research and development program, with a focus on innovation and sustainability. Zoetis has made significant investments in digital technologies, which have helped the company to improve its operational efficiency and enhance customer experience.
Zoetis has a strong financial position, with a market capitalization of over $80 billion. The company has consistently delivered strong financial results, with revenue of $6.3 billion in 2020, up 6% from the previous year. Zoetis has a diversified revenue stream, with products for livestock accounting for 70% of its revenue and products for companion animals accounting for the remaining 30%.
In conclusion, Zoetis is a leading animal health company with a strong leadership team, a robust research and development program, and a diversified portfolio of products. The company has a strong financial position and has consistently delivered strong financial results. Zoetis is well-positioned to capitalize on the growing demand for animal health products and is a solid investment option for stock market investors.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists ZOETIS INC's shareholders in Q3 2023. To view ZOETIS INC's shareholder history, click here.